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Clinics and pathology 
Disease 
Acute myeloid leukemia with maturation (AML M2) in 
one case only. 
Phenotype/cell stem origin 
CD13+, CD33+, CD34+, and CD117+ blast population 




Single case involving 74 year old male. 
Clinics 
A 74-year-old Caucasian male patient with progressive 
weakness and fatigue without any ‘B symptoms’. 
Evolution 
Despite intensive induction chemotherapy with Ara-C, 
Mitoxantrone, Topotecan and Mylotarg, no remission 
was obtained. The patient developed prolonged 
pancytopenia and remained transfusion-dependent. 
Prognosis 
The patient died five months after diagnosis from an 
episode of febrile neutropenia. 







About 24.4 kb in size and contains 7 exons. 
Protein 
PRDX4 is one of six peroxiredoxin-family genes, all of 
which are highly conserved in eukaryotes and 
prokaryotes and are ubiquitously expressed, being 
highest in pancreas, liver, heart and lowest in small 
intestine, thymus, spleen, and brain, and undetectable 
in peripheral-blood leukocytes. They use redox-active 
cysteines to reduce peroxides. In contrast to the 
intracellular localization of other family members, 
PRDX4 exists uniquely in the plasma, where the 
reduced form binds as a homodimer to heparan sulfate 
on endothelial cell surfaces. PRDXs are also implicated 
in a number of cellular functions such as cell 
proliferation and differentiation, enhancement of 
natural killer cell activity, protection of free radical 
sensitive proteins, hemoglobin metabolism, and 
intracellular signaling. PRDX4 plays a regulatory role 
in the activation of the transcription factor NF-kB by 
modulating IkB -alpha phosphorylation in the 
cytoplasm, and thus it is an immediate regulator of 
H2O2-mediated activation of NF-kB. In addition, 
PRDX1 or PRDX2 null mice have hemolytic anemia 
and several malignancies including lymphoma, 
indicating the essential role of these genes in 






Transcription from telomere to centreomere. 
Protein 
Contains the RUNT binding domain at 5' portion and  
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the transactivation domain at 3' portion. Forms 
heterodimers; widely expressed; nuclear localization; a 
transcription factor and critical regulator of 
hematopoietic-cell development. 




AML1 is fused to PRDX4 in-frame. Two in-frame 
AML1-PRDX4 fusion transcripts were detected with 
alternative splicing of exon 6 of AML1. One was the 
fusion between exon 5 of AML1 and exon 2 of 
PRDX4; the other was between exon 6 of AML1 and 
PRDX4. 
Transcript 
No PRDX4-AML1 fusion transcript was detected. 
Fusion protein 
Description 
Contains the RUNT binding domain of AML1 at 5' 
portion and two highly conserved cysteine residue 
motifs of PRDX4 in 3' portion. The first exon of the  
PRDX4 gene codes for a signal peptide that allows the 
secretion of the PRDX4. The first exon is lost as a 
result of the translocation. 
Oncogenesis 
The hybrid gene could function with a dominant-
negative effect on the normal AML1. The hybrid gene 
contains two cysteine residue motifs of the PRDX4 at 
the 3' portion, but not the signal peptide which allows 
the secretion of PRDX4, thus resulting in loss of at 
least one function of PRDX4 due to non-secretion. 
Recently, microarray studies on leukemia samples 
showed PRDX4 was down-regulated in APL with 
t(15;17) compared with all other AML samples. 
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